| " Incidence of different KRAS mutation in non-small cell lung cancer (NSCLC) patients, TAILOR STUDY O Martelli, E Rulli, A Bettini, G Farina, F Longo, L Moscetti, I Pavese, ... | | 2011 |
| ∆ Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299 E Caiola, E Marrazzo, S Alesci, M Broggini, M Marabese Tumor Biology 37, 2015-2021, 2016 | | 2016 |
| 1143 POSTER KRAS Mutational Status Strongly Impact Progression Free Survival of Patients Treated With Platinum Based Chemotherapy in NSCLC-Final Results of a Multicenter … M Marabese, E Rulli, A Bettini, G Farina, F Longo, L Moscetti, I Pavese, ... European Journal of Cancer, S137, 2011 | | 2011 |
| 18 O-Characterization of a protein which recognizes DNA damaged by minor groove binders G Colella, P Beccaglia, M Bonfanti, P De Feudis, S Marchini, M D’Incalci, ... European Journal of Cancer 32, S4, 1996 | | 1996 |
| 3 to 5 manuscripts R Alfieri, R Aly, S Arulananda, T Berghmans, P Bironzo, L Bubendorf, ... Journal of Thoracic Oncology 18 (4), 377-378, 0 | | |
| 308 POSTER Antitumor activity of the new aureolic acid derivatives mithramycin SDK and SK in human ovarian cancer xenografts S Previdi, V Albertini, M Nur-e-Alam, I Kwee, M Broggini, GM Carbone, ... EJC Supplements 12 (4), 97, 2006 | 1 | 2006 |
| 4-Demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin (PNU-159548), a Novel Anticancer Agent Active against Tumor CellLines with Different Resistance Mechanisms S Marchini, G Damia, M Broggini, G Pennella, M Ripamonti, A Marsiglio, ... Cancer research 61 (5), 1991, 2001 | 18 | 2001 |
| 467 Different KRAS Mutations Confer Different Sensitivity to Cisplatin in Non Small Cell Lung Cancer M Marabese, E Caiola, P Rusconi, S Piva, M Garassino, G Farina, ... European Journal of Cancer, 144-145, 2012 | 1 | 2012 |
| 481 POSTER Expression of genes involved in DNA damage response pathways in ovarian cancers G Damia, M Ganzinelli, P Mariani, R Fruscio, C Mangioni, M Broggini Ejc Supplements 12 (6), 153-154, 2008 | | 2008 |
| 500 POSTER Investigating the role of Nucleotide Excision Repair (NER) in the antitumor activity of Nemorubicin MA Sabatino, C Geroni, M Broggini EJC Supplements 12 (4), 152, 2006 | 2 | 2006 |
| 543 In vitro evidences on the role of the halogenoacrylic moiety in modulating brostallicin mechanism of action I Beria, S Marchini, M Colombo, M Broggini, C Geroni EJC Supplements 8 (2), 165-166, 2004 | | 2004 |
| 558 Antitumor activity of brostallicin on human prostatic cancer cells: fundamental role of combination with hypomethylating agents MA Sabatino, C Geroni, M Broggini EJC Supplements 8 (2), 170, 2004 | | 2004 |
| 601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair F Ricci, F Guffanti, M Fratelli, P Perego, R Fruscio, R Baldo, S Magni, ... European Journal of Cancer 50 (S5), S145-S145, 2014 | | 2014 |
| 731: Studies on the modulation of cisplatin activity in NSCLC by KRAS: Role of specific mutations at codon 12 E Caiola, R Frapolli, M Broggini, MC Garassino, G Farina European Journal of Cancer, S175-S176, 2014 | | 2014 |
| 767 Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization F Ricci, P Perego, F Bono, F Guffanti, R Fruscio, M Betti, F Dell'Orto, ... european journal of cancer, S182, 2012 | | 2012 |
| 922 DRAGO, a P53/p73 Regulated Gene That Modulates Survival in Tumour Prone Mouse Model P Rusconi, F Polato, A Musi, M Broggini european journal of cancer, S223, 2012 | | 2012 |
| A new somatic mutation in the coding region of KRAS gene (G48A) found in a NSCLC patient E Caiola, M Marabese, MC Garassino, G Rastelli, G Settanni, S Brugnara, ... European Journal of Cancer 1 (61), S180, 2016 | | 2016 |
| A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1, 3, 4, 5, 6-pentakisphosphate M Falasca, D Chiozzotto, HY Godage, M Mazzoletti, AM Riley, S Previdi, ... British Journal of Cancer 102 (1), 104-114, 2010 | 62 | 2010 |
| A SINGLE INJECTION OF COPPER SULPHATE RESTORES OXIDASE ACTIVITY IN BLOOD SERUM OF MAMMALS FED BY FODDER WITH SILVER IONS E Iliecheva, A Skvortsov, E Zatulovsky, N Tsymbalenko, P Ruskoni, ... Микроэлементы в медицине 11 (2), 24a-24a, 2010 | | 2010 |
| A siRNA high-throughput screening identified Wee1 as determinant of Chk1 inhibitor sensitivity L Carrassa, R Chilà, M Lupi, F Ricci, M Mazzoletti, C Celenza, M Broggini, ... Cancer Research 72 (8_Supplement), 4699-4699, 2012 | | 2012 |
damia giovannaChief, DNA repair unit, Mario negri institute在 marionegri.it 的电子邮件经过验证
